Oncolytic Poxviruses

被引：77

作者：

Chan, Winnie M. ^{[1
]}

McFadden, Grant ^{[1
]}

机构：

[1] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA

来源：

ANNUAL REVIEW OF VIROLOGY, VOL 1 | 2014年 / 1卷

关键词：

vaccinia virus; myxoma virus; virus tropism; oncolytic; virotherapeutics; virotherapy; ENVELOPED VACCINIA VIRUS; CANCER-RELATED ANEMIA; MYXOMA-VIRUS; CLINICAL-TRIAL; TUMOR-GROWTH; HUMAN-ERYTHROPOIETIN; APOPTOTIC MIMICRY; THYMIDINE KINASE; IMMUNE-RESPONSES; CELL CARRIERS;

D O I：

10.1146/annurev-virology-031413-085442

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Current standard treatments of cancer can prolong survival of many cancer patients but usually do not effectively cure the disease. Oncolytic virotherapy is an emerging therapeutic for the treatment of cancer that exploits replication-competent viruses to selectively infect and destroy cancerous cells while sparing normal cells and tissues. Clinical and/or preclinical studies on oncolytic viruses have revealed that the candidate viruses being tested in trials are remarkably safe and offer potential for treating many classes of currently incurable cancers. Among these candidates are vaccinia and myxoma viruses, which belong to the family Poxviridae and possess promising oncolytic features. This article describes poxviruses that are being developed for oncolytic virotherapy and summarizes the outcomes of both clinical and preclinical studies. Additionally, studies demonstrating superior efficacy when poxvirus oncolytic virotherapy is combined with conventional therapies are described.

引用

页码：191 / 214

页数：24

共 147 条

[11] An oncolytic vaccinia virus expressing the human sodium iodine symporter prolongs survival and facilitates SPECT/CT imaging in an orthotopic model of malignant pleural mesothelioma [J].

Belin, Laurence J. ;

Ady, Justin W. ;

Lewis, Christina ;

Marano, Drew ;

Gholami, Sepideh ;

Mojica, Kelly ;

Eveno, Clarisse ;

Longo, Valerie ;

Zanzonico, Pat B. ;

Chen, Nanhai G. ;

Szalay, Aladar A. ;

Fong, Yuman .

SURGERY, 2013, 154 (03) :486-495

[12] Viruses for Tumor Therapy [J].

Bell, John ;

McFadden, Grant .

CELL HOST & MICROBE, 2014, 15 (03) :260-265

[13] Vaccinia virus strain differences in cell attachment and entry [J].

Bengali, Zain ;

Townsley, Alan C. ;

Moss, Bernard .

VIROLOGY, 2009, 389 (1-2) :132-140

[14] Cancer-related anemia and recombinant human erythropoietin - an updated overview [J].

Bohlius, J ;

Weingart, O ;

Trelle, S ;

Engert, A .

NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (03) :152-164

[15]

Boulter E A, 1973, Prog Med Virol, V16, P86

[16] Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene [J].

Brader, Peter ;

Kelly, Kaitlyn J. ;

Chen, Nanhai ;

Yu, Yong A. ;

Zhang, Qian ;

Zanzonico, Pat ;

Burnazi, Eva M. ;

Ghani, Rashid E. ;

Serganova, Inna ;

Hricak, Hedvig ;

Szalay, Aladar A. ;

Fong, Yuman ;

Blasberg, Ronald G. .

CLINICAL CANCER RESEARCH, 2009, 15 (11) :3791-3801

[17] Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans [J].

Breitbach, Caroline J. ;

Burke, James ;

Jonker, Derek ;

Stephenson, Joe ;

Haas, Andrew R. ;

Chow, Laura Q. M. ;

Nieva, Jorge ;

Hwang, Tae-Ho ;

Moon, Anne ;

Patt, Richard ;

Pelusio, Adina ;

Le Boeuf, Fabrice ;

Burns, Joe ;

Evgin, Laura ;

De Silva, Naomi ;

Cvancic, Sara ;

Robertson, Terri ;

Je, Ji-Eun ;

Lee, Yeon-Sook ;

Parato, Kelley ;

Diallo, Jean-Simon ;

Fenster, Aaron ;

Daneshmand, Manijeh ;

Bell, John C. ;

Kirn, David H. .

NATURE, 2011, 477 (7362) :99-U102

[18] Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: No shortcuts on the road to approval [J].

Breitbach, Caroline J. ;

Reid, Tony ;

Burke, James ;

Bell, John C. ;

Kirn, David H. .

CYTOKINE & GROWTH FACTOR REVIEWS, 2010, 21 (2-3) :85-89

[19] DELETION OF THE VACCINIA VIRUS GROWTH-FACTOR GENE REDUCES VIRUS VIRULENCE [J].

BULLER, RML ;

CHAKRABARTI, S ;

COOPER, JA ;

TWARDZIK, DR ;

MOSS, B .

JOURNAL OF VIROLOGY, 1988, 62 (03) :866-874

[20] CELL PROLIFERATIVE RESPONSE TO VACCINIA VIRUS IS MEDIATED BY VGF [J].

BULLER, RML ;

CHAKRABARTI, S ;

MOSS, B ;

FREDRICKSON, T .

VIROLOGY, 1988, 164 (01) :182-192

← 1 2 3 4 5 6 7 8 9 10 →